Search Results - "Samudio, Ismael J"

Refine Results
  1. 1

    Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML by Zeng, Zhihong, Xi Shi, Yue, Samudio, Ismael J., Wang, Rui-Yu, Ling, Xiaoyang, Frolova, Olga, Levis, Mark, Rubin, Joshua B., Negrin, Robert R., Estey, Elihu H., Konoplev, Sergej, Andreeff, Michael, Konopleva, Marina

    Published in Blood (11-06-2009)
    “…SDF-1α/CXCR4 signaling plays a key role in leukemia/bone marrow microenvironment interactions. We previously reported that bone marrow–derived stromal cells…”
    Get full text
    Journal Article
  2. 2

    Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML by Zeng, Zhihong, Sarbassov, Dos D., Samudio, Ismael J., Yee, Karen W.L., Munsell, Mark F., Ellen Jackson, C., Giles, Francis J., Sabatini, David M., Andreeff, Michael, Konopleva, Marina

    Published in Blood (15-04-2007)
    “…The mTOR complex 2 (mTORC2) containing mTOR and rictor is thought to be rapamycin insensitive and was recently shown to regulate the prosurvival kinase AKT by…”
    Get full text
    Journal Article
  3. 3

    Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias by Zeng, Zhihong, Samudio, Ismael J, Munsell, Mark, An, Jing, Huang, Ziwei, Estey, Elihu, Andreeff, Michael, Konopleva, Marina

    Published in Molecular cancer therapeutics (01-12-2006)
    “…The chemokine receptor CXCR4 mediates the migration of hematopoietic cells to the stroma-derived factor 1α (SDF-1α)–producing bone marrow microenvironment…”
    Get full text
    Journal Article
  4. 4

    MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy by Kojima, Kensuke, Konopleva, Marina, Samudio, Ismael J., Shikami, Masato, Cabreira-Hansen, Maria, McQueen, Teresa, Ruvolo, Vivian, Tsao, Twee, Zeng, Zhihong, Vassilev, Lyubomir T., Andreeff, Michael

    Published in Blood (01-11-2005)
    “…Although TP53 mutations are rare in acute myeloid leukemia (AML), inactivation of wild-type p53 protein frequently occurs through overexpression of its…”
    Get full text
    Journal Article
  5. 5

    Effects of the breed, sex and age on cellular content and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel by Giraldo, Carlos E, López, Catalina, Álvarez, María E, Samudio, Ismael J, Prades, Marta, Carmona, Jorge U

    Published in BMC veterinary research (12-02-2013)
    “…There is no information on the effects of the breed, gender and age on the cellular content and growth factor (GF) release from equine pure-platelet rich…”
    Get full text
    Journal Article
  6. 6

    Concomitant Inhibition of MDM2 and Bcl-2 Protein Function Synergistically Induce Mitochondrial Apoptosis in AML by Kojima, Kensuke, Konopleva, Marina, Samudio, Ismael J, Schober, Wendy D, Bornmann, William, Andreeff, Michael

    Published in Cell cycle (Georgetown, Tex.) (01-12-2006)
    “…Disruption of Mdm2-p53 interaction activates p53 signaling, disrupts the balance ofantiapoptotic and proapoptotic Bcl-2 family proteins and induces apoptosis…”
    Get full text
    Journal Article
  7. 7

    Mitogen-activated protein kinase kinase inhibition enhances nuclear proapoptotic function of p53 in acute myelogenous leukemia cells by KOJIMA, Kensuke, KONOPLEVA, Marina, SAMUDIO, Ismael J, RUVOLO, Vivian, ANDREEFF, Michael

    Published in Cancer research (Chicago, Ill.) (01-04-2007)
    “…Activation of the Raf/MEK/ERK pathway and inactivation of wild-type p53 by Mdm2 overexpression are frequent molecular events in acute myelogenous leukemia…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Effects over time of two platelet gel supernatants on growth factor, cytokine and hyaluronan concentrations in normal synovial membrane explants challenged with lipopolysaccharide by Ríos, Diana L, López, Catalina, Álvarez, María E, Samudio, Ismael J, Carmona, Jorge U

    Published in BMC musculoskeletal disorders (20-06-2015)
    “…Platelet-rich plasma (PRP) preparations are a common treatment in osteoarthritis (OA) and inflammatory synovitis. However, there is ambiguity regarding the…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Autologous Platelet Concentrates as an Adjunctive Treatment for Chronic Laminitis in a Mare with Pituitary Pars Intermedia Dysfunction by Carmona, Jorge U., López, Catalina, Samudio, Ismael J.

    Published in Journal of equine veterinary science (01-03-2013)
    “…The aim of this article was to describe a case of a 7-year-old mare with chronic laminitis secondary to pituitary pars intermedia dysfunction that was…”
    Get full text
    Journal Article
  12. 12

    Activation of p53 signaling by MI-63 induces apoptosis in acute myeloid leukemia cells by Samudio, Ismael J., Duvvuri, Seshagiri, Clise-Dwyer, Karen, Watt, Julie C., Mak, Duncan, Kantarjian, Hagop, Yang, Dajun, Ruvolo, Vivian, Borthakur, Gautam

    Published in Leukemia & lymphoma (01-05-2010)
    “…Non-mutational inactivation of p53 is frequent in acute myeloid leukemia (AML) via overexpression of MDM2. We report that treatment with MI-63, a novel…”
    Get full text
    Journal Article
  13. 13

    HDAC inhibition by SNDX-275 (Entinostat) restores expression of silenced leukemia-associated transcription factors Nur77 and Nor1 and of key pro-apoptotic proteins in AML by Zhou, L, Ruvolo, V R, McQueen, T, Chen, W, Samudio, I J, Conneely, O, Konopleva, M, Andreeff, M

    Published in Leukemia (01-06-2013)
    “…Nur77 and Nor1 are highly conserved orphan nuclear receptors. We have recently reported that nur77 −/− nor1 −/− mice rapidly develop acute myeloid leukemia…”
    Get full text
    Journal Article
  14. 14

    Synergistic Activation of p53 Family of Proteins by the Combination of Nutlin 3a and SAHA in Acute Myelogenous Leukemia by Borthakur, Gautam, Duvvuri, Seshagiri, Samudio, Ismael J., Kojima, Kensuke, Konopleva, Marina, Andreeff, Michael

    Published in Blood (20-11-2009)
    “…Abstract 1738 Poster Board I-764 Nutlin 3a binds to murine double minute 2 (MDM2) a negative regulator of p53 and potently increases p53 protein levels by…”
    Get full text
    Journal Article
  15. 15

    Pharmacological Inhibition of Fatty Acid Oxidation as a Novel Therapeutic Concept for Acute Myeloid Leukemia by Andreeff, Michael, Fiegl, Michael, Konopleva, Marina, Korchin, Borys, Kaluarachchi, Kumar, Bornmann, William G., Guthrie, Patrick H., Harmancey, Romain, Taegtmeyer, Heinrich, Samudio, Ismael J.

    Published in Blood (20-11-2009)
    “…Abstract 3779 Poster Board III-715 Otto Warburg proposed that the origin of cancer cells was closely linked to a permanent respiratory defect that bypassed the…”
    Get full text
    Journal Article
  16. 16

    CXCR4 Expression and Biological Activity Is Dependent on Oxygen Partial Pressure in Acute Myeloid Leukemia by Fiegl, Michael, Samudio, Ismael J., Dwyer, Karen Clise, Burks, Jared, Fritsche, Herbert, Mnjoyan, Zakar H., Andreeff, Michael

    Published in Blood (16-11-2008)
    “…CXCR4, the receptor for bone marrow stroma derived SDF-1, has recently been studied in normal hematopoiesis and hematologic malignancies. Increased expression…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Targeting the Hypoxic Microenvironment by mTOR Inhibitors Sensitizes ALL Cells to Chemotherapy by Frolova, Olga, Samudio, Ismael J., Mnjoyan, Zakar H., Lu, Hongbo, Konoplev, Sergej, Thomas, Deborah A., Kantarjian, Hagop M., Shpall, Elizabeth J., Andreeff, Michael, Konopleva, Marina

    Published in Blood (16-11-2008)
    “…The main therapeutic challenge in the treatment of Acute Lymphocytic Leukemia (ALL) is the development of strategies aimed at overcoming resistance to…”
    Get full text
    Journal Article
  19. 19

    Apoptosis Inducing Factor Acts as a Survival Factor in Acute Myelogenous Leukemia through Mitochondrial Complex 1 by Wang, Rui-yu, Samudio, Ismael J., McQueen, Teresa, Schober, Wendy D., Ruvolo, Vivian R., Kornblau, Steven, Konopleva, Marina, Andreeff, Michael

    Published in Blood (16-11-2007)
    “…Apoptosis inducing factor (AIF) is a mitochondrial flavoprotein that is released into the cytoplasm to form an active DNase and then translocates into the…”
    Get full text
    Journal Article
  20. 20

    Activation of p53 signaling by MI-63 induces apoptosis in acute myelogenous leukemia cells by Samudio, Ismael J, Duvvuri, Seshagiri, Clise-Dwyer, Karen, Watt, Julie C, Mak, Duncan, Kantarjian, Hagop, Yang, Dajun, Ruvolo, Vivian, Borthakur, Gautam

    Published in Leukemia & lymphoma (01-05-2010)
    “…Non-mutational inactivation of p53 is frequent in acute myeloid leukemia (AML) via overexpression of MDM2. We report that treatment with MI-63, a novel…”
    Get full text
    Journal Article